Australia Stock Exchange release from AVECHO BIOTECHNO : Topical CBD pain study with Lambert Initiative approved
20/10/2021 22:49
Australia Stock Exchange release from AVECHO BIOTECHNO AVE.AX : Topical CBD pain study with Lambert Initiative approved
Recent news on Avecho Biotechnology
See all newsBrief: Avecho Biotechnology Seeks Trading Halt
Australia's Avecho Biotechnology falls on discounted placement
Brief: Avecho Biotechnology Raises A$2.5M Via Placement
Brief: Avecho And Sandoz Enter Exclusive License And Development Agreement
Brief: Avecho Biotechnology Seeks Trading Halt Pending Release Of Information About License And Development Agreement